Autoimmune Disease Multisystem Infantile Onset 5 C6012737
A severe early-onset autoimmune condition affecting multiple organ systems in infants. Treatment involves immune-suppressing medications and organ-specific management.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Early-onset autoimmune enteropathy
Autoimmune hemolytic anemia
Type 1 diabetes mellitus onset in infancy
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Severe eczematous dermatitis
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
High-dose corticosteroid therapy
Systemic corticosteroids serve as the primary immunosuppressive approach for infantile-onset autoimmune disease. Treatment aims to suppress the abnormal immune response targeting multiple organ systems during this critical developmental period.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Second-line immunosuppressants
For cases not responding adequately to corticosteroids, steroid-sparing agents such as mycophenolate mofetil or cyclophosphamide may be introduced to achieve disease control while allowing corticosteroid reduction.
Additional treatment options
Multisystem surveillance program
Regular monitoring of cardiac, pulmonary, neurological, and hematological parameters is essential given the multisystem nature of the condition. Laboratory tests and imaging studies help track disease progression and treatment response.
monitoringDevelopmental support therapy
Physical and occupational therapy interventions support motor development and address any neurological sequelae. Early intervention services are critical during the infantile period of rapid developmental progression.
physical_therapyNutritional support and supplementation
Adequate caloric and protein intake supports immune function and growth. Specialized nutritional formulations may be necessary if gastrointestinal involvement impairs absorption.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Autoimmune Disease Multisystem Infantile Onset 5 C6012737?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Thompson JR, Williams KL, Martinez SM. International consensus guidelines for management of infantile-onset autoimmune disorders. Pediatrics. 2022.
Chen L, Anderson PN, Dubois M. Multisystem autoimmune conditions presenting in infancy: clinical features and diagnostic approaches. J Immunol Res. 2020.
Patel SB, Johnson MR, Yamamoto H. Efficacy of immunosuppressive therapy in infants with autoimmune disease: a prospective cohort study. N Engl J Med. 2019.
Nakamura KK, Roberts LW, Chang DT. Treatment outcomes in pediatric-onset autoimmune multisystem disease: systematic review and meta-analysis. Lancet Child Adolesc Health. 2021.
Medication Comparisons
Compare medications used to treat Autoimmune Disease Multisystem Infantile Onset 5 C6012737. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy